Christine Katlama Selected Research

Raltegravir Potassium

1/2021	Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc.
12/2020	The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.
10/2020	Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine.
1/2020	Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
11/2017	Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.
1/2017	Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.
11/2015	Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
4/2015	Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia.
6/2014	Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
3/2013	Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Katlama Research Topics

Disease

32	Infections 01/2022 - 01/2002
24	HIV Infections (HIV Infection) 01/2018 - 05/2003
14	Acquired Immunodeficiency Syndrome (AIDS) 10/2016 - 04/2003
12	Viremia 01/2020 - 11/2008
9	Neoplasms (Cancer) 01/2022 - 01/2006
9	Hepatitis B 11/2017 - 01/2002
7	Fibrosis (Cirrhosis) 12/2020 - 03/2003
7	Coinfection 11/2017 - 03/2003
6	Inflammation (Inflammations) 01/2021 - 01/2012
5	Liver Cirrhosis (Hepatic Cirrhosis) 10/2013 - 03/2003
4	Insulin Resistance 12/2020 - 02/2009
4	Persistent Infection 02/2015 - 05/2002
4	Human Influenza (Influenza) 07/2013 - 02/2008
4	Exanthema (Rash) 01/2010 - 09/2003
4	Disease Progression 01/2008 - 10/2002
3	Lipodystrophy 04/2022 - 02/2016
3	Nausea 11/2017 - 12/2005
3	Hypersensitivity (Allergy) 06/2014 - 09/2003
3	Chronic Hepatitis C 01/2014 - 07/2004
3	Hepatitis C 11/2010 - 01/2005
3	Encephalitis (Encephalitis, Rasmussen) 09/2010 - 03/2002
3	Opportunistic Infections (Opportunistic Infection) 01/2006 - 12/2002
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 01/2019
2	Weight Gain 12/2020 - 10/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2020
2	Hypertension (High Blood Pressure) 01/2019 - 07/2011
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 03/2008
2	Headache (Headaches) 11/2017 - 02/2007
2	Necrosis 07/2017 - 01/2012
2	Metabolic Bone Diseases (Osteopenia) 11/2015 - 09/2013
2	Urolithiasis 01/2014 - 09/2007
2	Virus Diseases (Viral Diseases) 04/2012 - 07/2004
2	Hepatitis 11/2010 - 04/2010
2	Injection Site Reaction 09/2010 - 12/2005
2	Thrombocytopenia (Thrombopenia) 12/2009 - 07/2004
1	COVID-19 03/2022
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Lymphoma (Lymphomas) 01/2020
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2020
1	Myocardial Infarction 01/2020
1	Melanoma (Melanoma, Malignant) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Progressive Multifocal Leukoencephalopathy 01/2018

Drug/Important Bio-Agent (IBA)

21	RNA (Ribonucleic Acid)IBA 01/2019 - 05/2003
15	Raltegravir Potassium FDA Link 01/2021 - 07/2008
10	NucleosidesIBA 01/2022 - 05/2003
9	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 03/2004
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2004
8	Reverse Transcriptase InhibitorsIBA 01/2022 - 05/2003
8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2012
8	Tenofovir (Viread)FDA Link 11/2017 - 02/2007
8	VaccinesIBA 02/2016 - 12/2002
8	Ritonavir (Norvir)FDA Link 01/2014 - 05/2003
6	Atazanavir Sulfate (Reyataz)FDA Link 01/2020 - 05/2006
6	Biomarkers (Surrogate Marker)IBA 10/2014 - 03/2003
5	etravirine (TMC-125)FDA Link 10/2020 - 11/2009
5	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2004
5	Lamivudine (Epivir)FDA Link 07/2009 - 01/2002
4	AntibodiesIBA 03/2022 - 01/2006
4	Maraviroc FDA Link 01/2021 - 11/2010
4	dolutegravirIBA 12/2020 - 03/2013
4	Emtricitabine (Emtriva)FDA Link 11/2017 - 01/2011
4	InterferonsIBA 01/2017 - 05/2006
4	abacavir (Ziagen)FDA Link 11/2015 - 09/2003
4	Proteins (Proteins, Gene)FDA Link 02/2015 - 12/2002
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2012 - 03/2005
3	IntegrasesIBA 01/2022 - 01/2018
3	Integrase InhibitorsIBA 12/2020 - 04/2009
3	Darunavir (Prezista)FDA Link 01/2020 - 04/2007
3	Alanine Transaminase (SGPT)IBA 01/2019 - 02/2009
3	Indinavir (Crixivan)FDA Link 01/2014 - 05/2003
3	efavirenz (Sustiva)FDA Link 01/2011 - 09/2007
3	Enfuvirtide (Fuzeon)FDA Link 09/2010 - 12/2005
3	Interleukin-2 (IL2)IBA 03/2008 - 01/2002
2	EnzymesIBA 04/2022 - 10/2009
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2019 - 02/2009
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 11/2010
2	CreatinineIBA 11/2015 - 06/2007
2	BilirubinIBA 01/2014 - 02/2011
2	Foscarnet FDA LinkGeneric 06/2012 - 01/2006
2	Stavudine (Zerit)FDA LinkGeneric 01/2012 - 04/2007
2	Viral RNAIBA 01/2012 - 01/2004
2	Nevirapine (Viramune)FDA Link 01/2011 - 09/2003
2	Hepatitis B e AntigensIBA 01/2011 - 03/2006
2	CytokinesIBA 05/2010 - 04/2010
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 10/2009 - 01/2006
2	adefovir dipivoxil (Hepsera)FDA Link 01/2008 - 05/2002
2	insulin receptor-related receptor (IRR)IBA 01/2008 - 03/2005
2	Lopinavir FDA Link 08/2006 - 11/2005
2	Interferon alpha-2 (Roferon-A)FDA Link 05/2006 - 07/2004
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2020
1	pembrolizumabIBA 01/2019
1	NivolumabIBA 01/2019

Therapy/Procedure

38	Therapeutics 01/2022 - 04/2003
14	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 03/2002
4	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
2	Immunotherapy 01/2022 - 01/2019
2	Duration of Therapy 04/2010 - 02/2009